David Loew
Chief Executive Officer at IPSEN
Net worth: 59 562 $ as of 2024-03-30
Profile
David G. Loew is Chief Executive Officer & Director at Ipsen SA and Chief Executive Officer at Ipsen Pharma SAS (a subsidiary of Ipsen SA). In the past he was Executive Vice President-Sanofi Pasteur at Sanofi and Global Head-Product Strategy at Genentech, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IPSEN SA
0.00% | 2022-12-30 | 500 ( 0.00% ) | 59 562 $ | 2024-03-30 |
David Loew active positions
| Companies | Position | Start |
|---|---|---|
| IPSEN | Chief Executive Officer | 2020-06-30 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Chairman | 2020-07-29 |
| European Federation of Pharmaceutical Industries & Assoc | Director/Board Member | - |
| G5 Santé | Director/Board Member | - |
Former positions of David Loew
| Companies | Position | End |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 2020-06-14 |
| GAVI Alliance | Director/Board Member | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of David Loew
| University of St. Gallen | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| SANOFI | Health Technology |
| IPSEN | Health Technology |
| Private companies | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| GAVI Alliance | Miscellaneous |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
| European Federation of Pharmaceutical Industries & Assoc | |
| G5 Santé |
- Stock Market
- Insiders
- David Loew
